Suzhou Fushilai Pharmaceutical Co., Ltd. engages in the research, development, production and sale of pharmaceutical intermediates, active pharmaceutical ingredients and raw materials for health care products. It offers lipoic acid, phosphatidylcholine and carnosine products. The company was founded in 1997 and is headquartered in Suzhou, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company